WA
IART icon

WPG Advisers’s Integra LifeSciences IART Stock Holding History

WPG Advisers’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$245 Sell
26
-24
-48% -$264 ﹤0.01% 1421
2025
Q4 		$621 Hold
50
– – ﹤0.01% 1357
2025
Q3 		$717 Buy
50
+1
+2% +$14 ﹤0.01% 1320
2025
Q2 		$601 Hold
49
– – ﹤0.01% 1333
2025
Q1 		$1.08K Buy
49
+25
+104% +$588 ﹤0.01% 1236
2024
Q4 		$544 Buy
+24
New +$524 ﹤0.01% 1331

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WPG Advisers's IART Position: Q1 2026 in Review

WPG Advisers reduced its Integra LifeSciences (IART) stake by 48% in Q1 2026, selling an estimated $264 and leaving 26 shares worth $245. The position accounts for ﹤0.01% of the portfolio, ranked #1421.

WPG Advisers first reported a position in IART in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.08K in Q1 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • WPG Advisers held 26 shares of Integra LifeSciences worth $245 as of Q1 2026.
  • WPG Advisers sold 24 Integra LifeSciences shares in Q1 2026, an estimated $264.
  • Integra LifeSciences made up ﹤0.01% of WPG Advisers's portfolio in Q1 2026, its #1421 holding.
  • WPG Advisers first reported a position in Integra LifeSciences in Q4 2024 and has held it in 6 quarters since.
  • WPG Advisers's Integra LifeSciences position peaked at $1.08K in Q1 2025.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on WPG Advisers's 13F filing for Q1 2026, filed 30 Apr 2026.